)
Edge31 Oct 2025
Rolls-Royce: Full Thrust Ahead
From century-old crafted perfection to pandemic shock and reset, Rolls-Royce's story is shaped by heritage, turbulence, and a disciplined climb back.
Strides Pharma Science (STAR) investor relations material
Strides Pharma Science Q2 25/26 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q2 25/26 earnings summary31 Oct, 2025
Executive summary
Q2 FY26 revenue grew 4.6% year-on-year to ₹12,208 million, with operational PAT up 84% to ₹1,403 million and EPS at ₹15.2, up 83.8% year-on-year.
H1 FY26 revenue rose 5.5% year-on-year to ₹23,406 million, with operational PAT at ₹2,543 million, up 82.6% year-on-year, and EPS at ₹27.6, up 82.2% year-on-year.
Profit after tax from continuing operations for Q2 FY26 was ₹1,315 million, compared to ₹723 million in Q2 FY25.
Growth was primarily driven by Other Regulated Markets and disciplined execution across all key markets.
A major demerger of the CDMO and Soft Gelatin business was completed, resulting in a one-time gain of ₹31,881 million, presented as discontinued operations.
Financial highlights
Q2 gross margin at ₹706 crore (57.8%), up 500 bps year-on-year; H1 gross margin at ₹1,381 crore (59%), up 410 bps.
Q2 EBITDA at ₹2,316 million (19% margin), up 25.4% year-on-year; H1 EBITDA at ₹4,500 million (19.2% margin).
Q2 operational PAT at ₹1,403 million, highest ever; operational EPS at ₹15.2.
Net debt reduced by ₹733 million in H1 FY26 after funding ₹1,492 million of capex from internal accruals.
Q2 FY26 finance income included a one-time income of ₹185 million.
Outlook and guidance
Long-term U.S. revenue target of $400 million by FY28 remains intact, with 60 dormant ANDAs to be relaunched over the next 3 years.
Other Regulated Markets expected to mirror U.S. market size in 2-3 years, with portfolio expansion and new customer acquisitions.
H2 is expected to be better than H1, continuing the historical trend.
Growth Markets expected to have lumpy quarters until business stabilizes in the next two years.
The business is now evaluated as a single segment, "Pharmaceutical," following the demerger.
Core profit growth post demerger?
Future impact of product recall litigations?
Risk from unreviewed subsidiary financials?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Strides Pharma Science earnings date
Q3 25/2629 Jan, 2026
Next Strides Pharma Science earnings date
Q3 25/2629 Jan, 2026
The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Strides Pharma Science Limited is a pharmaceutical company engaged in the development, manufacturing, and distribution of generic medicines. The company specializes in niche and complex formulations across various therapeutic areas, including antibiotics, oncology, central nervous system, and dermatology. It operates a global network of manufacturing facilities and supplies products to regulated markets, including the United States, Europe, and emerging economies. The company is headquartered in Bengaluru, India, and its shares are listed on the Bombay Stock Exchange (BSE) and the National Stock Exchange of India (NSE).
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage